Equities

Biotechnology Assets SA

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Biotechnology Assets SA

Actions
  • Price (EUR)0.19
  • Today's Change0.005 / 2.43%
  • Shares traded96.97k
  • 1 Year change-42.94%
  • Beta1.4145
Data delayed at least 15 minutes, as of Feb 20 2026 16:36 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, Biotechnology Assets SA (BST:MCE) closed at 0.19, 7.95% above its 52-week low of 0.176, set on Jan 07, 2026.
52-week range
Today
0.176Jan 07 20260.489Jul 01 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.1865
High0.191
Low0.182
Bid0.184
Offer0.1905
Previous close0.1855
Average volume130.68k
Shares outstanding72.81m
Free float39.19m
P/E (TTM)--
Market cap13.51m EUR
EPS (TTM)-0.0363
EUR
Data delayed at least 15 minutes, as of Feb 20 2026 16:36 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.